Recruiting

A Phase 2, Open-Label Study of DISC-3405 in Participants With Polycythemia Vera (PV)

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(14 sites)

United States

Mayo Clinic in Arizona, Phoenix, Arizona

USC Norris Comprehensive Cancer Center, Los Angeles, California

UCLA Health, Los Angeles, California

Keck Medicine of USC - Cancer Clinic- Newport Beach, Newport Beach, California

Mayo Clinic in Florida, Jacksonville, Florida

Mayo Clinic in Minnesota, Rochester, Minnesota

Siteman Cancer Center - Washington University St. Louis, St Louis, Missouri

Atrium Health - Levine Cancer Center, Charlotte, North Carolina

Duke University, Durham, North Carolina

Atrium Health Wake Forest Baptist Medical Center, Winston-Salem, North Carolina

Ohio State University, Columbus, Ohio

Oregon Health & Science University, Portland, Oregon

MD Anderson Cancer Center, Houston, Texas

University of Washington - Fred Hutchinson Cancer Research Center, Seattle, Washington